[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"chronic-disease-management\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:chronic-disease-management":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,51,78,105],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":32,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":39,"lastUpdatePostDateStruct":40,"startDateStruct":43,"completionDateStruct":45,"leadSponsor":47,"locationsCount":50},"100616646","taining-golden-lake-comprehensive-chronic-disease-management-initiative-100616646",false,"NCT07308314","Taining Golden Lake Comprehensive Chronic Disease Management Initiative","TAIGOLD-CDM","Inclusion Criteria:\n\n* Age ≥18 years, male or female.\n* Resident of Taining County for ≥6 months and expected to remain in the county for at least the next 3 years.\n* Full civil capacity and able to understand study procedures.\n* Willing to voluntarily participate and provide written informed consent.\n* Able to complete baseline survey and follow-up visits.\n\nExclusion Criteria:\n\n* Refusal to sign informed consent.\n* Severe psychiatric disorders or cognitive impairment preventing participation.\n* End-stage disease with expected survival \\\u003C1 year.\n* Long-term migrants (≥6 months per year outside the county), unable to guarantee follow-up.\n* Participation in other clinical studies that may interfere with this research.",true,"ALL","18 Years",{"count":20,"type":21},20000,"ESTIMATED","OBSERVATIONAL","This study aims to establish the first county-level, population-based prospective cohort in Taining County, Fujian Province, China. The cohort will include at least 20,000 residents aged 18 years or older. The project will systematically collect questionnaires, physical measurements, laboratory tests, imaging data, and biological samples to build a multi-dimensional health database and biobank. Through 3-year follow-up, the study seeks to reveal the epidemiological patterns and risk factors of chronic diseases, characterize the natural course of multimorbidity and aging syndromes, and develop a comprehensive chronic disease management model suitable for rural and mountainous regions.",[25,26,27,28,29,30,31],"Chronic Disease","Chronic Disease Management","Hypertension","Diabetes Mellitus","Dyslipidemias","Frailty","Sarcopenia",[26,33,27,28,34,35,30,31,36,37],"Prospective Cohort","Dyslipidemia","Cardiovascular Disease","Aging","Healthy Aging","RECRUITING","2025-12-15",{"date":41,"type":42},"2025-12-29","ACTUAL",{"date":44,"type":42},"2025-08-01",{"date":46,"type":21},"2028-07-01",{"name":48,"class":49},"First Affiliated Hospital of Fujian Medical University","OTHER",1,{"id":52,"slug":53,"hasResults":11,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":4,"eligibilityCriteria":57,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":58,"targetDuration":4,"studyType":60,"phases":61,"briefSummary":63,"conditions":64,"keywords":4,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":50},"100613319","integrated-tcm---western-medicine-strategy-for-long---distance-diabetes-management-100613319","NCT07265037","Integrated TCM - Western Medicine Strategy for Long - Distance Diabetes Management","Development of a New Integrated Strategy for Long-Distance and Full-Course Management of Diabetes Using Both Traditional Chinese and Western Medicine: A Combined Online and Offline Approach","Inclusion Criteria:\n\n* Presence of typical diabetes symptoms (polyuria, polydipsia, polyphagia, and unexplained weight loss) AND meeting any one of the following laboratory criteria: Fasting venous plasma glucose ≥ 7.0 mmol\u002FL, or Random plasma glucose ≥ 11.1 mmol\u002FL, or Glycated hemoglobin (HbA1c) ≥ 6.5%.\n* OR, meeting the following oral glucose tolerance test criteria:Fasting plasma glucose ≥ 7.0 mmol\u002FL AND 2-hour plasma glucose ≥ 11.1 mmol\u002FL after a 75g glucose load.\n\nExclusion Criteria:\n\n* Comorbidities that may prevent compliance with the study protocol, including but not limited to: active malignancy, rheumatic autoimmune diseases, severe infections, multiple organ failure, or psychiatric disorders.",{"count":59,"type":21},10000,"INTERVENTIONAL",[62],"NA","The management of diabetes is of great value in reducing the risk of complications and alleviating the socioeconomic burden. Currently, the diabetes management models in China have not effectively integrated the advantages of traditional Chinese medicine (TCM) and Western medicine. They also fail to achieve intelligent and automated management, resulting in high management costs and low efficiency. Therefore, it is extremely urgent to explore a new, efficient, convenient, low - cost, and personalized long - distance, full - course, intelligent management model for diabetes that integrates TCM and Western medicine both online and offline.\n\nBased on this, our research group plans to rely on the pre - designed and developed Idata database. We will deeply integrate the diagnostic and treatment advantages of TCM constitution differentiation and Western medical examinations and laboratory tests, construct an automated follow - up path, and build an integrated online diabetes management platform for Internet hospitals, which consists of \"intelligent hardware + APP + cloud services + a back - end think - tank of TCM and Western medicine experts + a back - end professional management and care team\".\n\nThis initiative aims to blaze a new trail in the field of long - distance, full - course, and personalized management of diabetes through the synergy of TCM and Western medicine for Chinese diabetes patients. We expect to significantly reduce the incidence of diabetes complications, remarkably improve the overall health status and quality of life of patients, and bring unprecedented positive impacts on the well - being of diabetes patients.",[65,66,67,26,68],"Diabetes Mellitus, Type 2","Integrated Traditional Chinese Medicine and Western Medicine","Telemedicine","Digital Health","2025-11-23",{"date":71,"type":42},"2025-12-04",{"date":73,"type":42},"2025-11-01",{"date":75,"type":21},"2026-05-31",{"name":77,"class":49},"Shanxi Bethune Hospital",{"id":79,"slug":80,"hasResults":11,"nctId":81,"briefTitle":82,"officialTitle":82,"acronym":83,"eligibilityCriteria":84,"healthyVolunteers":16,"sex":17,"minAge":85,"maxAge":4,"enrollmentInfo":86,"targetDuration":88,"studyType":22,"phases":4,"briefSummary":89,"conditions":90,"keywords":93,"overallStatus":95,"whyStopped":4,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":97,"startDateStruct":99,"completionDateStruct":101,"leadSponsor":103,"locationsCount":4},"100595547","comprehensive-geriatric-assessment-in-chronic-disease-management-for-older-adults-in-china-a-registry-study-cgacdm---older-adults-in-china-100595547","NCT07033871","Comprehensive Geriatric Assessment in Chronic Disease Management for Older Adults in China: A Registry Study （CGACDM - Older Adults in China）","CGACDM - Older","Inclusion Criteria:\n\n* 1\\. Aged 60 years or older 2. Diagnosed with chronic diseases in the circulatory, respiratory, digestive, nervous, or endocrine systems, consistent with corresponding disease diagnostic criteria; 3. Availability of complete medical records; 4. Clear consciousness and ability to independently answer questions; 5. Signed informed consent form.\n\nExclusion Criteria:\n\n* 1\\. Presence of any condition\u002Fcircumstance which in the opinion of the investigator could significantly limit the complete follow up of the patient (e.g. tourist, non-native speaker or does not understand the local language, psychiatric disturbances).\n\n  2\\. Presence of serious\u002Fsevere co-morbidities in the opinion of the investigator which may limit short term (i.e. 6 month) life expectancy.\n\n  3\\. Current participation in a randomised interventional clinical trial.","60 Years",{"count":87,"type":21},1000,"5 Years","With the continuous development of China's economy and the improvement of medical standards, the life expectancy of the Chinese population has significantly increased. Against the backdrop of accelerating aging in China, the incidence of age-related chronic non-communicable diseases (NCDs), such as cardiovascular and cerebrovascular diseases and chronic respiratory diseases, has risen remarkably. These diseases are characterized by multiple comorbidities, high disability rates, and high mortality rates, severely compromising the quality of life of older adults, exacerbating family burdens, and straining healthcare systems. This constitutes one of the major challenges faced by aging societies. Therefore, early detection and intervention of chronic diseases in older adults are critical measures to address population aging.\n\nComprehensive geriatric assessment (CGA), a core specialty of geriatric medicine, serves as a fundamental framework for the clinical identification of geriatric syndromes and multidisciplinary management. It is emerging as a key pathway to promote \"healthy aging.\" Guided by this premise, this study aims to explore the application value of CGA in managing chronic diseases among older adults, with the goal of achieving full-cycle management for early detection, diagnosis, and treatment of chronic conditions in China's elderly population.",[91,26,92],"Comprehensive Geriatric Assessment","Older Adults (65 Years and Older)",[91,26,94],"Older Adults","NOT_YET_RECRUITING","2025-06-14",{"date":98,"type":42},"2025-06-24",{"date":100,"type":21},"2025-07-01",{"date":102,"type":21},"2030-05-01",{"name":104,"class":49},"Henan Provincial People's Hospital",{"id":106,"slug":107,"hasResults":11,"nctId":108,"briefTitle":109,"officialTitle":109,"acronym":4,"eligibilityCriteria":110,"healthyVolunteers":11,"sex":17,"minAge":111,"maxAge":112,"enrollmentInfo":113,"targetDuration":4,"studyType":60,"phases":115,"briefSummary":116,"conditions":117,"keywords":122,"overallStatus":95,"whyStopped":4,"lastUpdateSubmitDate":126,"lastUpdatePostDateStruct":127,"startDateStruct":129,"completionDateStruct":131,"leadSponsor":133,"locationsCount":5},"100592415","a-multi-site-hybrid-type-i-effectiveness-implementation-randomized-trial-of-an-emergency-care-action-plan-for-infants-with-medical-complexity-100592415","NCT06993129","A Multi-Site Hybrid Type I Effectiveness-Implementation Randomized Trial of an Emergency Care Action Plan for Infants With Medical Complexity","Inclusion Criteria:\n\n* Age 0 to 6 months\n* Admitted to the University of Vermont Medical Center, Cincinnati Children's Hospital, Children's Hospital of Philadelphia, or Colorado Children's Hospital Neonatal Intensive Care Unit (NICU),\n* Meets or is expected to meet Children with Medical Complexity status as determined by the treating NICU clinician and defined as \"children with multiple significant chronic health problems including multiple organ systems, which result in functional limitations, high health care needs or utilization, and often require need for, or use of, medical technology.\"\n* Has three or more documented complex chronic conditions (CCCs)\n\nExclusion Criteria:\n\n* Does not have a caregiver participant who agrees to their participation in the study to complete follow-up surveys\n* Does not intend to use the hospital or affiliated sites of which they were recruited from for care during the one-year trial period","0 Months","6 Months",{"count":114,"type":21},500,[62],"Infants with medical complexity (IMC) are a challenging population with more emergency department visits, inpatient stays, and higher healthcare costs than other children. IMC also experience lower quality emergency health care. The PI and team propose to adapt and put into place an emergency care action plan (ECAP) for IMC across four US hospitals, working directly with medical providers and families in each setting. After the tool is made available to providers and families, the PI and team will measure if the ECAP tool helps decrease the number of hospitalizations (primary research outcome) for IMC, as well as if the ECAP is feasible, acceptable, and useable for those using the ECAP over a one-year period.",[26,118,119,120,121],"Infants Health","Emergency","Utilization, Health Care","Caregiver Stress",[123,124,125],"Children with Medical Complexity","Hybrid Implementation Trial","Health Service Utilization","2025-06-03",{"date":128,"type":42},"2025-06-06",{"date":130,"type":21},"2026-04-01",{"date":132,"type":21},"2031-06-01",{"name":134,"class":49},"University of Vermont"]